UTHR Financial Facts
Net income per diluted common share (in dollars per share): 3.5Diluted (in shares): 46.2M
See Full Income Statement
Marketable investments: 79.6M
Other current assets: 36.4M
See Full Balance Sheet
United Therapeutics Corp. (UTHR) Earnings
|
Expand Research on UTHR
| Next EPS Date | 5/1/24 | EPS Growth Rate | +19.1% |
|---|---|---|---|
| Average EPS % Beat Rate | +6.1% | Revenue Growth Rate | +22.3% |
| Average % Move 1-Wk after EPS | -0.1% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2/22/23 | Q422 | $2.67 | $4.72 | -$2.05 | $491.5M | $519.21M | N/A |  | | Details | |
| 8/2/23 | Q223 | $5.24 | $4.57 | +$0.67 | $596.5M | $524.18M | N/A | | | Details | |
4/28/16  |
 |
Q116 | N/A | $3.21 | N/A | $369M | $397.42M | N/A | N/A | N/A | |
| 2/15/11 |
|
Q410 | $1.27 | $0.62 | +$0.65 | $166.5M | $174.87M | N/A | | | Details |
| 5/1/24 | Q124 | N/A | $5.79 | N/A | N/A | $619.94M | N/A | N/A | N/A | ||
| 2/14/13 | Q412 | N/A | $1.24 | N/A | N/A | $233.41M | N/A | N/A | N/A | ||
| 5/3/23 | Q123 | $4.86 | $4.54 | +$0.32 | $506.9M | $512.69M | N/A | | | Details | |
| 11/2/22 | Q322 | $4.91 | $4.06 | +$0.85 | $516M | $493.81M | N/A | | | Details |
